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Abstract
Myogenesis is a highly regulated process that involves the conver-
sion of progenitor cells into multinucleated myofibers. Besides
proteins and miRNAs, long noncoding RNAs (lncRNAs) have been
shown to participate in myogenic regulatory circuitries. Here,
we characterize a murine chromatin-associated muscle-specific
lncRNA, Charme, which contributes to the robustness of the
myogenic program in vitro and in vivo. In myocytes, Charme deple-
tion triggers the disassembly of a specific chromosomal domain
and the downregulation of myogenic genes contained therein.
Notably, several Charme-sensitive genes are associated with
human cardiomyopathies and Charme depletion in mice results in
a peculiar cardiac remodeling phenotype with changes in size,
structure, and shape of the heart. Moreover, the existence of an
orthologous transcript in human, regulating the same subset of
target genes, suggests an important and evolutionarily conserved
function for Charme. Altogether, these data describe a new exam-
ple of a chromatin-associated lncRNA regulating the robustness of
skeletal and cardiac myogenesis.
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Introduction
Myogenesis is a highly regulated multistep process, in which the
conversion of progenitor cells into multinucleated and functional
myofibers can be easily reproduced in vitro. Besides the well-charac-
terized protein factors and miRNAs (Buckingham & Rigby, 2014),
also long noncoding RNAs (lncRNAs) have been shown to partici-
pate in myogenic regulatory circuitries (Rinn & Chang, 2012; Fatica
& Bozzoni, 2014; Ballarino et al, 2015). lncRNAs, through their abil-
ity to interact with nucleic acids as well as with proteins (Guttman
& Rinn, 2012; Rinn & Chang, 2012; Batista & Chang, 2013; Cipriano
& Ballarino, 2018), act as scaffolds for the formation of specific func-
tional complexes where different proteins and RNA and even DNA
molecules can be tethered together (Wutz et al, 2002; Clemson
et al, 2009; Tsai et al, 2010; Ariel et al, 2014; Hacisuleyman et al,
2014; Ribeiro et al, 2017). Nuclear lncRNAs have been described to
control the transcriptional myogenic program through diverse
modes of action (Ballarino et al, 2016): as enhancer-associated tran-
scripts (Mousavi et al, 2014; Mueller et al, 2015; Ounzain et al,
2015), as guides for the recruitment of PRCs and MLL epigenetic
regulators or DNA methyltransferases (DNMT; Wang et al, 2015,
2016), and also as allosteric inhibitors (Han et al, 2014; Wang et al,
2016). Important functions have also been ascribed to cytoplasmic
lncRNAs through their ability to control mRNA stability and transla-
tion (Wang et al, 2013), to modulate miRNA function acting as
competing endogenous RNA (Cesana et al, 2011; Salmena et al,
2011; Han et al, 2015), or to encode for micropeptides (Anderson
et al, 2015; Nelson et al, 2016). Interestingly, de-regulation of these
molecules was often associated with skeletal (Ballarino et al, 2015)
and cardiac (Han et al, 2014; Ounzain & Pedrazzini, 2015; Uchida &
Dimmeler, 2015; Wang et al, 2016) diseases.
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We recently identified a novel nuclear lncRNA, Charme (Chro-
matin architect of muscle expression), conserved in human and
with restricted expression in skeletal and cardiac muscles (Ballarino
et al, 2015). Here, we show that the depletion of Charme produces
the downregulation of myogenic genes, many of which involved in
human cardiomyopathies (Becker et al, 2011; Harvey & Leinwand,
2011). Through a combination of ChIRP and FISH approaches, we
identified a Charme/chromatin interaction that is required for the
correct expression of a subset of relevant myogenic genes. Notably,
the functional knockout of Charme in mice produced morphological
alterations of both skeletal and cardiac muscles and resulted in a
shorter life span. The structural and functional conservation of
Charme in human further corroborates its relevance in the control
of proper muscle differentiation and homeostasis.
Results
Charme is a chromatin-associated long noncoding RNA
Previous transcriptome analysis from murine C2C12 myoblasts and
myotubes discovered novel lncRNAs with muscle restricted expres-
sion (Ballarino et al, 2015). Among them, lnc-405, here named
Charme (Chromatin architect of muscle expression; Figs 1A and
EV1A), is a novel isoform of the 5430431A17Rik transcript of partic-
ular interest for (i) its specific expression in both skeletal and
cardiac muscles, (ii) its predominant nuclear localization, and (iii)
the presence of an orthologue transcript in human.
The expression of Charme was studied by 50-RACE, Northern
blot, and RT–PCR analyses (Figs 1B and EV1B): It is predominantly
localized in the nucleus, mainly associated with the chromatin, with
a minor fraction being present in the cytoplasm. In C2C12 cells, RNA
FISH showed a well-defined punctate localization of Charme in the
nuclei of myofibers defined as multinucleated cells expressing the
myogenic marker myosin heavy chain (MHC). Charme was instead
absent in proliferating myoblasts, identified as mononucleated cells
lacking MHC staining (Fig 1C). Charme expression starts at day 1
upon shift to differentiation medium (DM), reaching high levels at
day 3 (Fig 1D). In agreement with RNA-seq data, RT–PCR analyses
revealed the existence of an isoform (pCharme) still retaining intron
1 and devoid of intron 2 (Figs 1A and D, and EV1C and D). Notably,
actinomycin experiments indicated that this isoform was as stable
as the fully spliced Charme species (mCharme; Fig EV1E). RNA
FISH with intron probes detected an average of three nuclear spots
which co-localize with the exonic signals (Appendix Fig S1A and B).
This pattern, whose specificity was tested by both RNaseA and
RNAi sensitivity (Appendix Fig S1C), well correlates with the
aneuploidy of C2C12 cells having three copies of chromosome 7,
where Charme locus resides. The number, the intensity, and the
focal plane distribution of the signals obtained with exonic vs.
intronic probes allowed us to establish that the major fraction
of Charme is retained at the sites of its own transcription as a
precursor species.
Charme depletion affects myogenesis
To analyze the role of Charme in myogenesis, we treated C2C12
myotubes with two different LNA GAPmers (GAP-2 and GAP-2/3;
Fig 1A), which provided 60–70% average reduction in both intron
1-harboring (pCharme) and mature (mCharme) Charme transcripts
(Fig 1E). Upon knockdown, 50% decrease of the mRNAs for two
diagnostic markers of differentiation, myosin creatine kinase (MCK)
and the myosin heavy chain (MHC), was found (Fig 1E and
Table EV1) indicating quite a clear impairment of myogenesis.
Morphological parameters were also specifically affected: a consis-
tent reduction in the caliber of differentiated MHC-positive
myotubes (Fig 1F) was observed, together with a decrease of more
than twofold of the fusion index (F.I.) and of the number of nuclei
per fiber (Nu/MT). In parallel, the number of mononucleated
(MonoMHC+) cells increased by a factor of 3 (Fig 1G). These results
suggest that Charme inhibition mainly affects the ability of
myogenic cells to fuse and to proceed to later stages of differentia-
tion.
RNA-seq analysis on cells treated with GAP-2 or GAP-2/3, in
parallel with a scramble control (Appendix Fig S2A and B) led to the
identification of a set of 826 genes differentially expressed upon
Charme depletion with two different sets of LNA GAPmers (Fig 2A
and Appendix Fig S2C). Of these, 302 were upregulated and 524
downregulated in comparison with the scramble condition (Fig 2A
and Table EV1). Real-time quantitative PCR on a selected number of
targets confirmed the sequencing data (Appendix Fig S2D). The
Gene Ontology (GO) term enrichment study performed with the
FIDEA web tool (D’Andrea et al, 2013) suggested that Charme may
act by activating genes involved in muscle function and contraction
▸Figure 1. Charme is a novel long noncoding transcript associated with myogenesis.A Genomic structure of the Charme locus. The position of PCR primers, LNA GAPmers (GAP-2, GAP-2/3), and in situ probes (green—intronic; or red—exonic) used in this
study are shown together with the produced Charme isoforms.
B Semiquantitative RT–PCR (sqRT–PCR) quantification of pCharme and mCharme in cytoplasmic (Cyt), nuclear (Nu), nucleoplasmic (Np), or chromatin (Chr) fractions
from 2-day differentiated myotubes. The quality of fractionation was tested with mature (GAPDH) and precursor (pre-GAPDH) RNAs.
C Co-staining of MHC protein (green) and Charme RNA (red) in fully differentiated myotubes. DAPI, 40 ,6-diamidino-2-phenylindole. MHC, myosin heavy chain. Scale
bar = 10 lm.
D sqRT–PCR quantification of Charme amplicons in growth (GM) and differentiated (DM) conditions. GAPDH mRNA serves as control. , RT-minus control.
E Real-time RT–PCR (qRT–PCR) quantification of mCharme and pCharme, MCK, and MHC in differentiated myotubes treated with GAP-2, GAP-2/3, or GAP-scr as negative
control. Data were normalized to GAPDH mRNA and represent mean  SD of triplicates.
F Immunofluorescence staining for MHC on C2C12 cells treated with GAP-scr, GAP-2, or GAP-2/3 (right) and merged with the DAPI staining (left). Scale bar = 100 lm.
G Quantification of myotubes formation (F.I., Nu/MT, MonoMHC+) on cells treated with GAP-2, GAP-2/3, or GAP-scr. Bars represent mean  SD of triplicates of
randomly chosen microscope fields.
Data information: *P < 0.05, **P < 0.01, ***P < 0.001, paired Student’s t-test.
Source data are available online for this figure.
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processes (Fig 2B). To note, we did not observe significant enrich-
ment of any cell-cycle- and/or proliferation-related categories.
Interestingly, Charme depletion resulted in the downregulation of
genes (i.e., Myh7 and Tnnt2; Appendix Fig S2E) implicated in
several types of cardiomyopathies (Fig 2C), such as familial hyper-
trophic (HCM), dilated (DCM), and arrhythmogenic right ventricular
(ARVC) cardiomyopathies (Harvey & Leinwand, 2011; Becker et al,
2011; Maron et al, 2012).
pCharme is localized at specific chromosomal sites
To elucidate Charme mode of action, we proceeded with the identifi-
cation of the sites of chromatin interaction in C2C12 cells. Chromatin
isolation by RNA purification (ChIRP) analysis was carried out with
two different pools of four alternating antisense biotinylated
oligonucleotides (even and odd), together with four oligonucleotides
against lacZ sequences (Appendix Fig S2F). Figure 2D (panel RNA)
shows that a specific pull-down of pCharme isoform was obtained
when compared to the lacZ control and the GAPDH pre-mRNA,
while no enrichment was obtained for mCharme isoform. The co-
purified DNA was subjected to high-throughput sequencing (ChIRP-
seq), and the reads from odd and even pull-downs were compared
to those of the lacZ control (Table EV2). In agreement with the
strong chromatin association, the major peak corresponded to the
Charme locus. Several other genomic loci were identified
(Table EV2); among them, the most prominent corresponded to a
region (hereafter named as nctc) located on the same Charme chro-
mosome (chr7:149,746,850–149,747,033) and containing several
genes affected by Charme depletion (Appendix Fig S2G and
Table EV1). The nctc peak was validated by PCR amplification on
the initial ChIRP samples (Fig 2D, panel DNA) and reproduced in
independent replicates. Interestingly, this region contains a shared
core muscle enhancer (CME; Alzhanov et al, 2010) required for
muscle-specific activation of Igf2 and H19 (Eun et al, 2013), which
are both decreased upon Charme knockdown (Table EV1). Interest-
ingly, the knockout of part of this enhancer was previously shown
to produce the loss of Igf2 expression and defects in muscle differen-
tiation (Kaffer et al, 2001). Therefore, for subsequent analysis we
concentrated on this specific locus.
The physical association of pCharme RNA with nctc (98 Mb far
from Charme locus) was validated by FISH analysis with probes
against Charme RNA (red) and BAC probes against the target loci
(green). A detailed quantification of the signals indicated that in
more than 60% of the nuclei Charme is in close proximity with the
nctc region, with 2/3 of the signals showing partial overlapping
(Fig 2E). No proximity was instead found when the unrelated lnc-31
locus (Ballarino et al, 2015), which was absent in the ChIRP-seq
dataset, was used as negative control (Fig 2E).
Notably, the surrounding 2.5 Mb of the ChIRP peak in the nctc
region contains relevant myogenic genes, such as Igf2, Tnnt3, and
Tnni2, that were downregulated upon Charme depletion in the
RNA-seq dataset (Tables EV1 and EV2). qRT–PCR confirmed their
downregulation upon Charme depletion both at the mRNA and pre-
mRNA levels (Fig 2F). Along this line, ChIP analyses performed in
conditions of Charme downregulation showed a strong decrease in
the association of the RNA polymerase II (RNA Pol II) and in the
acetylation of lysine K9 histone 3 (H3K9ac) of these genes (Fig 2G).
Altogether, these data indicate that the effect of Charme on these
target genes is exerted at the transcriptional level.
Due to the strong accumulation of pCharme at the sites of its
own transcription, we tested whether the Charme genomic locus
itself could be in contact with nctc. To this purpose, FISH analyses
were performed with DNA BAC probes flanking the Charme gene
(red) or overlapping the nctc region (green; Figs 3 and EV2A–C). In
GM conditions, when Charme is not expressed, the two districts are
clearly distinguished as independent spots (Fig 3A, left panel, and
Fig EV2C, GM). Notably, upon Charme expression, the two regions
get close (Fig EV2C, DM1 and DM1.5, and Fig EV2D) with a consis-
tent percentage of chromosomes showing overlapping or proximal
signals at days 1 and 1.5 of differentiation (Fig 3A, right panels, and
Fig EV2C). As control, no proximity was found with the unrelated
lnc-31 locus (Figs 3A and EV2C, lower panels). Notably, the
pCharme-mediated long-range interaction was significantly reduced
when Charme was downregulated by 50% through GAP-2 treatment
(Figs 3B and EV2E). Overall, these in vitro data suggest an impor-
tant role of pCharme in a long-range physical interaction between
two chromatin districts distantly located, but present on the same
chromosome.
◀ Figure 2. Charme regulates myogenesis by interacting with the nctc region.A RNA-seq analysis of transcriptome changes upon Charme depletion. Heatmap was drawn using the heatmap3 R package and represents hierarchical clustering of the
common genes differentially expressed upon Charme depletion with both GAP-2 and GAP-2/3 GAPmers, compared to GAP-scr control. The expression levels
correspond to mean-centered log2-transformed FPKM values. See also Table EV1.
B Gene Ontology (GO) term enrichment analyses performed by FIDEA (D’Andrea et al, 2013) on genes downregulated (top) or upregulated (bottom) upon Charme
depletion. Bars indicate the top 10 categories of cellular components in decreasing order of significance. Threshold (P-value < 0.01) is indicated by the dashed black
line.
C KEGG pathway enrichment analysis on genes downregulated by Charme depletion.
D Quantification of recovered RNA (left) and DNA (right) upon Charme ChIRP with the pool of biotinylated probes reported in Table EV4.
E RNA/DNA FISH for Charme RNA and nctc (left) or lnc-31 (right) loci in 2-day differentiated myotubes. Inserts show a magnification of the spots converted into binary
images (I), 3D rendering (II), or rotated on Z-axis (III). Yellow arrows indicate signals overlapping. Right histogram reports the mean  SD percentage of nuclei with
paired or overlapped spots from two biological replicates. Scale bar = 5 lm.
F qRT–PCR quantification of Charme and Charme target genes in GAP-scr- vs. GAP-2-transfected (2-day differentiated) myotubes. PCR data were normalized to GAPDH
and represent mean  SD of triplicates.
G RNA Pol II (left) and H3K9ac (right) ChIP performed in GAP-scr- vs. GAP-2-transfected myotubes. The recovered chromatin was analyzed by qPCR in parallel with an
intergenic region used to normalize the two (GAP-scr vs. GAP-2) conditions. Data were subtracted for background and are expressed as input percentage (% Input).
Histograms represent the mean  SEM of three biological replicates.
Data information: *P < 0.05, **P < 0.01, ***P < 0.001, unpaired Student’s t-test.
Source data are available online for this figure.
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A further evidence for Charme acting in the nucleus at the sites
of its own transcription derives from experiments where we tried to
rescue the phenotype of Charme depletion with a cDNA construct
expressing a GAPmer-resistant mCharme. This construct failed to
recover the expression of myogenic markers (Fig EV2F) and
produced a transcript with a cytoplasmic-restricted localization
(Fig EV2G). The lack of rescue with cytoplasmic RNA further
supports the finding that the active Charme species is the nuclear
one; moreover, these results are in line with the accepted notion
that for chromatin-associated lncRNAs acting in cis, rescue pheno-
types are not obtained with exogenous gene overexpression (Goff &
Rinn, 2015; Wang et al, 2015).
Charme functional knockout in mice affects the
myogenic process
In consideration of the interesting function of Charme observed
in vitro, the study of its function in vivo was strongly demanded.
Therefore, the CRISPR/Cas9 methodology was used to generate a
Charme null allele in mice. In order to avoid any structural alter-
ation of the locus, we inserted at the beginning of exon 2 the strong
poly(A) polyadenylation signal of the b-globin gene (Levitt et al,
1989) followed by two MAZ sites, known to promote efficient cleavage
and transcriptional termination (Yonaha & Proudfoot, 2000; Gromak
et al, 2006; Fig 4A). The correct genomic editing was confirmed in a
founder mouse, and the Charme null allele was backcrossed for four
generations to obtain homozygous animals (Fig EV3A). Charme/
mice are viable, fertile, and produced in Mendelian ratios. Analysis
of skeletal muscles of 1-month-old mutant and control animals indi-
cated that the insertion of the poly(A)/MAZ cassette resulted in a
very effective depletion of both pCharme and mCharme isoforms
(Fig 4B). The histological analysis of skeletal muscles from
Charme/ mice revealed a slight but significant reduction in the
area of the fiber sections (Fig 4C), which is the most common
parameter used to assess correct tissue morphology. Moreover, as a
further evidence for delayed differentiation, a significant decrease in
the mRNAs of myogenic markers myosin creatine kinase (MCK) and
myosin heavy chain (MHC) was observed (Fig 4D). These features
appeared consistent with the reduction in the fiber caliber of dif-
ferentiating myotubes and the decrease in myoblast fusion observed
in vitro in C2C12 cells (Fig 1G). Moreover, the Charme targets
located in the nctc region identified in C2C12 cells were also specifi-
cally affected in murine muscle tissues (Fig 4E).
Charme/ mice exhibit an altered cardiac phenotype
Since Charme also displays a cardiac restricted expression
(Ballarino et al, 2015), we analyzed the effects of Charme knock-
out in heart. A peculiar phenotype was detected when analyzing
the heart of Charme/ mice where the expression of both
pCharme and mCharme isoforms was almost abolished by the
poly(A) site insertion (Fig 5A). Morphometric analyses, performed
with hematoxylin/eosin staining in both adult (Fig 5B) and neona-
tal (Fig EV3B) cardiac sections, showed in all the mice tested an
increase in the heart area (Ha), a definite decrease in ventricular
chamber dimensions (LVa and RVa), and an increase in the thick-
ness of the ventricular free walls (LVw and RVw) and interventric-
ular septum (IVS; Fig EV3C). Moreover, as expected from this
altered morphology, higher blood pressures (DBP and SBP) and
heart-to-body weight ratio (Hw/Bw) were also detected in
Charme/ animals (Fig EV3D). Notably, compared to wild-type
littermates, which have a life expectancy of 24–38 months, none
of the available Charme/ mice (n = 5, P < 0.001) survived for
more than 1 year, suggesting a midlife lethality caused by Charme
ablation. In analogy to skeletal muscles, the histological analysis
performed on Charme/ cardiac tissues revealed a reduction in
cell area (Fig 5C) together with the downregulation of terminal dif-
ferentiation markers (Fig 5D). To note, the expression of Igf2, the
only gene of the nctc region expressed in the cardiac tissue, was
also found to be downregulated. Notably, in line with the in vitro
data, DNA/DNA FISH experiments performed in neonatal hearts
proved that the co-localization between Charme and the nctc
regions is also occurring in vivo while it is impaired in Charme/
animals (Fig 5E). Interestingly, the proximity was also found to
persist in adult hearts (Fig EV3E).
Identification of a functionally conserved human Charme
transcript
An evolutionary conservation analysis performed by examining
RNA-seq (Legnini et al, 2017) and FANTOM5 (Noguchi et al, 2017)
data revealed the existence of a Charme orthologue transcript (hs-
Charme) produced by the human syntenic locus (Fig EV4A), with a
structure very similar to the murine counterpart (Figs 6A and EV4B–
D, and Table EV3). Notably, the hs-Charme locus displays an overall
~ 45% sequence identity (Fig EV4E and Appendix Table S1), which
is a high value for a lncRNA genomic region (Pang et al, 2006). Simi-
larly to the murine counterpart (Ballarino et al, 2015), the expression
of the early myogenic transcriptional factor MyoD was found to
precede that of hs-Charme (Fig EV5A, left panel; and Table EV3) and
a specific peak of MyoD ChIP-seq (MacQuarrie et al, 2013) was iden-
tified, as in mouse, at the level of MyoD canonical E-boxes upstream
to the TSS (Fig EV5B and C). Altogether, these data suggest a
common regulatory control of MyoD on mouse and human Charme
RNA expression. Indeed, both hs-pCharme and hs-mCharme were
found expressed in human primary myoblasts upon induction of dif-
ferentiation; moreover, both transcripts resulted in delayed expres-
sion in myoblasts from Duchenne muscular dystrophy patients
(Figs 6B and EV5A, right panel; and Table EV3), where MyoD
expression is strongly impaired and cells are blocked in a more
◀ Figure 3. pCharme contributes to the maintenance of chromatin contacts with the nctc region.A Double DNA FISH for Charme and nctc (top) or Charme and lnc-31 (bottom) loci in growth (GM) and differentiated (DM1) conditions. Histograms represent the
percentages  SD of chromosome 7 showing paired and overlapped signals in GM, DM1, and DM1.5 days of differentiation from two biological replicates.
B DNA/DNA FISH for Charme and nctc loci in GAP-scr- vs. GAP-2-transfected myotubes (DM1). Percentage of Charme locus  SD from three biological replicates
showing paired and overlapped signals with nctc is indicated in the histograms below.
Data information: **P < 0.01, ***P < 0.001, unpaired Student’s t-test. Scale bar = 5 lm.
Source data are available online for this figure.
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B qRT–PCR quantification of mCharme and pCharme expression in skeletal homogenates from Charme+/+ and Charme/ mice. The number of mice tested is the same
for the two groups, and it is indicated in the white bars. Data were normalized to GAPDH mRNA and represent mean  SEM.
C Dystrophin staining analyzed by immunofluorescence on Charme+/+ and Charme/ skeletal (gastrocnemius) biopsies. The mean  SD of cross-sectional area (lm2) is
reported in the histograms besides. In total, N = 667 and 1,039 fibers per condition were analyzed. Original magnification = ×10. The number of mice tested is the
same for the two groups, and it is indicated in the white bars. Scale bar = 100 lm.
D qRT–PCR quantification of MHC and MCK transcripts in skeletal (gastrocnemius) homogenates from Charme+/+ and Charme/ mice. The number of mice tested is the
same for the two groups, and it is indicated in the white bars. Data were normalized to GAPDH mRNA and represent mean  SEM.
E qRT–PCR quantification of Tnnt3, Tnni2, and Igf2 transcripts in skeletal (gastrocnemius) homogenates from Charme+/+ and Charme/ mice. Data were normalized to
GAPDH mRNA and represent mean  SEM. The number of mice tested is the same for the two groups, and it is indicated in the white bars.
Data information: *P < 0.05, **P < 0.01, ***P < 0.001, unpaired Student’s t-test.
Source data are available online for this figure.
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proliferative state (Delaporte et al, 1984; Cazzella et al, 2012). Simi-
larly to the murine species, hs-pCharme is mainly accumulated in the
nucleus as an unprocessed species still containing intron 1 while the
fully spliced isoform (hs-mCharme) is mainly localized in the cyto-
plasm compartment (Fig 6C and D). In human primary myoblasts,
GAPmer-directed knockdown produced a strong downregulation of
both hs-pCharme and hs-mCharme transcripts as well as the
myogenic markers identified in mouse (Fig 6E). Altogether, these
data suggest a conserved role of Charme in mammalian myogenesis.
Discussion
In this study, we show the characterization of Charme, a chromatin-
associated lncRNA induced upon myogenic differentiation. In vitro
Charme knockdown causes defects in myoblast fusion and downreg-
ulation of several crucial myogenic genes. Among them, several
have been previously shown to be involved in familial hypertrophic
(HCM), dilated (DCM), and arrhythmogenic right ventricular (ARVC)
cardiomyopathies (Maron et al, 2012). Interestingly, an orthologue
transcript, hs-Charme, was identified in human myoblasts. Similarly
to its murine counterpart, hs-Charme is induced upon differentiation,
and its depletion affects the same subset of myogenic genes. These
data support the notion of an important conserved function of
Charme in mammalian myogenesis.
Through ChIRP analyses, we found that Charme associates with
several different genomic loci containing a number of the myogenic
genes affected by its depletion. One of these regions, nctc, seemed
particularly interesting because it is localized in cis with respect to
the Charme locus and harbors a shared core muscle enhancer (CME;
Alzhanov et al, 2010), previously shown to control muscle-specific
activation of the neighboring Igf2 and H19 promoters (Eun et al,
2013). Moreover, the knockout of part of the nctc region was
performed by several groups and resulted in the loss of Igf2 expres-
sion and in defective myogenesis (Kaffer et al, 2001; Alzhanov &
Rotwein, 2016). The nctc region also contains genes involved in
muscle activity and metabolism, such as muscle troponins (Tnni2
and Tnnt3). Interestingly, all these genes are affected by Charme
depletion, indicating a direct connection between the lncRNA
expression and the muscle-specific transcriptional output of the
region. We also show that Charme, retained at the sites of its own
transcription as an incompletely spliced form, is required for the
maintenance of the long-distance chromosomal interaction with the
nctc locus and for consolidating the expression of the myogenic
genes therein included. These data are in line with recent studies
indicating the importance of the tridimensional chromatin folding
and with the evidence that the eukaryotic genome is organized in a
hierarchy of well-defined, highly compartmentalized, and extremely
dynamic structures within the nucleus, where chromosome territo-
ries are segmented into functional compartments (Rowley & Corces,
2016). These regions can be considered as discrete regulatory units
where genes far apart in terms of linear distance but close in space
are activated or repressed in a coordinated fashion during cell dif-
ferentiation (Zaug & Cech, 1980; Guerrier-Takada et al, 1983).
Notably, Charme depletion in vivo produced similar molecular
and morphological phenotypes as the one observed in vitro. In fact,
◀ Figure 5. Charme/ mice exhibit an altered cardiac phenotype.A qRT–PCR quantification of mCharme and pCharme expression in cardiac homogenates from Charme+/+ and Charme/ mice. The number of mice tested (the same for
the two groups) is indicated in the white bars. Data were normalized to GAPDH mRNA and represent mean  SEM.
B Hematoxylin and eosin staining of transverse sections of the myocardium in 1-month-old Charme+/+ (left) and Charme/ (right) mice. Left (LV) and right (RV)
ventricles are indicated. Scale bar = 1 mm.
C Dystrophin staining analyzed by immunofluorescence on Charme+/+ and Charme/ cardiac tissues. The mean  SD of cross-sectional area (lm2) is reported in the
histograms besides. In total, N = 1,491 and 1,724 fibers per condition were analyzed. Original magnification = ×20. The number of mice tested is the same for the
two groups, and it is indicated in the white bars. Scale bar = 100 lm.
D qRT–PCR quantification of Myh7, Tnnt2, and Igf2 transcripts in cardiac homogenates from 1-month-old Charme+/+ and Charme/ mice. Data were normalized to
GAPDH mRNA and represent mean  SEM. The number of mice tested (the same for the two groups) is indicated in the white bars.
E DNA/DNA FISH for Charme and nctc loci in Charme+/+ and Charme/ neonatal (1 day old) cardiac tissues are shown. Percentage of Charme locus  SD showing
paired and overlapped signals with nctc is indicated in the histogram. N = 395 and 315 chromosome pairs per condition were analyzed. Scale bar = 5 lm.
Data information: *P < 0.05, ***P < 0.001, unpaired Student’s t-test.
Source data are available online for this figure.
▸Figure 6. Expression profiling and characterization of the human Charme upon in vitro differentiation of primary myoblasts.A The human Charme genomic locus is indicated together with the position of PCR primers (hs-2, hs-3) and LNA GAPmers (hs-GAP-int1, hs-GAP-ex2) used in this study.
B RT–PCR quantification of the human hs-pCharme (upper panel) and hs-mCharme (lower panel) in control healthy or dystrophic (DMD) primary myoblasts in
proliferating (GM) and differentiating (3, 6, 10) conditions. Data were normalized to GAPDH mRNA and represent mean  SD. Three biological replicates were
analyzed.
C sqRT–PCR quantification of hs-pCharme and hs-mCharme in cytoplasmic (Cyt) and nuclear (Nu) RNA fractions from differentiated myotubes. The quality of
fractionation was tested with precursor (pre-GAPDH) and mature (GAPDH) RNAs.
D Analysis by PCR amplification of hs-pCharme intron 1 retention. The position of the oligos used for the analyses is depicted aside.
E qRT–PCR quantification of hs-mCharme, hs-pCharme, MCK, MHC, Igf2, Tnnt3, Tnni2, and Dmd mRNAs in primary cells treated with hs-GAP-int1, hs-GAP-ex2, or hs-GAP-
scr GAPmers at day 5 of differentiation. PCR data were normalized to GAPDH mRNA and represent mean  SD of duplicates.
F Proposed model for pCharme mode of action: In proliferating myoblasts, Charme is not expressed and its chromatin locus is spatially distant from the nctc region; in
differentiated myotubes, pCharme stabilizes the physical proximity of the two loci allowing their co-regulated expression.
Data information: **P < 0.01, ***P < 0.001, unpaired Student’s t-test.
Source data are available online for this figure.
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the same genes affected in C2C12 cells were downregulated in the
skeletal muscles of Charme/ mice and the decrease in fiber cali-
bers observed in adult muscles correlated well with the reduction in
the caliber of differentiating myotubes observed in vitro. Charme/
mice showed also a clear cardiac phenotype, characterized by a
conspicuous decrease in fiber size, and resulting in an overall heart
remodeling and alteration of morphological and functional parame-
ters. Also in this district, Charme was shown to contribute to the
physical proximity with the nctc genomic region and to affect the
cardiac expression of Igf2. Since Charme depletion provides a clear
heart phenotype already at neonatal stages, the observed remodel-
ing of the cardiac tissue must represent outcomes of defects starting
early during embryonic development and persisting in adult life.
The reduction in life span observed in adult mice indicated the
persistence of effects of Charme depletion even at very advanced
ages. It is important to note that this is the first time that such a
cardiac phenotype has been directly ascribed to a lncRNA ablation
in the absence of any stressful condition (Guttman et al, 2010;
Devaux et al, 2015). Moreover, the chronic in vivo phenotype,
where the overall alteration of tissue homeostasis and cardiac struc-
ture leads to late lethality, correlates well with the role of Charme as
a fine-tuning regulator.
Since Charme is interacting with several other regions besides
the nctc locus, it is important to underline that these other domains
will likely contribute to the overall phenotype observed in vitro and
in vivo. For the nctc locus, which has been prioritized in this study,
a clear correlation between the expression of the myogenic genes
therein included and Charme activity has been assessed (Fig 6F).
Further characterization of the other Charme targets will be neces-
sary to complete the genome-wide clarification of its function in
skeletal and cardiac muscles.
Materials and Methods
Cell culture conditions and transfection
C2C12 murine myoblasts were cultured as previously described
(Agostini et al, 2013) and differentiated in 0.5% fetal bovine
serum (FBS). Human control healthy and DMD myoblasts from
the Telethon Neuromuscular Biobank were cultured as previously
described (Faghihi et al, 2008) and differentiated with human
skeletal muscle differentiation medium (PromoCell). RNAi experi-
ments were performed with 75 nM of LNA GAPmers (Exiqon)
using Lipofectamine 2000 (Invitrogen). GAPmers were designed
against Charme exon 2 (GAP-2) or EX2/EX3 splice junction
(GAP-2/3) sequences using the Exiqon web tool. Sequences are
reported in Table EV4.
RNA analyses
Total RNA from myoblasts/myotubes was isolated using QIAzol
Lysis Reagent (Qiagen)/chloroform extraction followed by spin-
column purification (RNeasy Mini Kit; Qiagen) and quantification
by NanoDrop (Thermo Scientific). Northern blot analysis was
performed on 12 lg of total RNA from mouse myoblasts/myotubes.
Total RNA was denatured in glyoxal loading dye (Ambion) for
30 min at 50°C and loaded on 1.2% agarose gel. Electrophoresis
was carried out for 2 h at 60 V. RNA was transferred overnight on
Hybond-N+ membrane (GE Healthcare) by capillarity in 10× SSC.
The transferred RNA was UV-cross-linked (1,200 × 100 lJ/cm2),
and the membrane was washed in 50 mM Tris (pH 8) for 20 min at
45°C. Pre-hybridization and hybridization were performed in North-
ernMax buffer (Ambion) at 68°C (30min and overnight, respec-
tively). For the hybridization, 500 ng of DIG-labeled probes
(DIG-RNA Labeling Mix; Roche) was produced by in vitro transcrip-
tion with T7 RNA polymerase (Promega) using a PCR-amplified
Charme template (see Table EV4 for oligo sequences). The
membrane was washed twice in 2× SSC/0.1% SDS and twice in
0.2× SSC/0.1% SDS at 68°C. The membrane was finally processed
for DIG detection using the DIG Luminescence Detection Kit
(Roche), according to the manufacturer’s instructions. Nucleo-
plasm/chromatin/cytoplasmic fractionation was performed using
the NE-PER Kit (Pierce-Thermo Scientific) following the manufac-
turer’s specifications. 50-RACE was performed using FirstChoice
RLM-RACE kit (Ambion) on 5 lg of total RNA and by PCR amplifi-
cation with Charme 4 and Charme 3 reverse primers. For semiquan-
titative and quantitative PCR analyses, RNA (0.5–1.0 lg) was
reverse-transcribed using SuperScript III RT (Life Technologies)
according to the manufacturer’s instructions and amplified by PCR
using MyTaq (Bioline) enzyme. Real-Time PCRs (qPCRs) were
performed using QuantiTect SYBR Green (Qiagen).
RNA-seq and functional enrichment analysis
RNA-seq data were analyzed using RAP (D’Antonio et al, 2015)
using FASTQC (www.bioinformatics.babraham.ac.uk), NGS QC
Toolkit (Patel & Jain, 2012), Bowtie 2 (Langmead & Salzberg, 2012),
TopHat2 (Kim et al, 2013), and Cufflinks and Cuffdiff (Trapnell
et al, 2012, 2013). Default parameters were used for the analyses
except for library type (fr-firststrand), mate inner distance (set to
30), standard deviation of inner distance (set to 60), and minimum
read length (set to 30). Reads were aligned using mm9 assembly.
Genes deregulated in both GAP-2 and GAP-2/3 conditions were
selected choosing Cuffdiff q-value < 0.1, abs(log2 fold change) >
0.5, and variation of gene expression in the same direction. Func-
tional enrichment analysis was performed by FIDEA (D’Andrea
et al, 2013) using the genes expressed in the scramble condition as
background.
RNA-seq data from GSE70389 (Legnini et al, 2017) were
analyzed as described above. The read coverage and the Cufflinks
tracks were loaded on IGV genome browser (Robinson et al, 2011;
Thorvaldsdo´ttir et al, 2013); see also Fig EV4B.
Chromatin isolation by RNA purification (ChIRP) sequencing
ChIRP-seq was performed according to the procedure described by
Chang (Chu et al, 2011) using nuclear extract from 107 differenti-
ated myotubes/each sample. Charme pull-down was performed with
different sets of oligos (Appendix Fig S2F) or lacZ as control. Input
and purified DNA were sequenced with HiSeq 2500 (40 million
single-end, 50-base pair-long reads/sample). Reads were pre-
processed with Trimmomatic (Bolger et al, 2014) and Cutadapt
(Martin, 2011) to trim the 50 and 30 adapters and to remove the first
five nucleotides, whose average quality score was lower than that of
the other nucleotides. Low-complexity reads were then removed
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using the DUST algorithm included in the PRINSEQ suite (Fatica &
Bozzoni, 2014; Morlando et al, 2014; complexity score thresh-
old = 7). The procedure adopted by Chu and colleagues (Chu et al,
2011) was used to find the EVEN and ODD common peaks (mm9
assembly, MACS14 bw = 300 (Zhang et al, 2008), fold enrichment/
input > 2, average coverage > 10, and Pearson correlation > 0.3).
BEDTools (Quinlan & Hall, 2010) was used to identify the overlap-
ping lacZ peaks (obtained with MACS14 using the input as back-
ground). Peaks with fold enrichment/input 25 times lower than that
of the overlapping lacZ peaks and with more than 50% of the length
covered by repeats (Chen, 2002; http://www.repeatmasker.org)
were excluded. HOMER (Heinz et al, 2010) was employed to anno-
tate peaks using GENCODE M4 (Harrow et al, 2012). WindowBed
tool was used to find all downregulated genes which are closer than
2.5 Mb to Charme ChIRP peaks.
Immunofluorescence and DNA/RNA FISH
MHC staining and dystrophin staining were performed as previously
described (Cazzella et al, 2012). Samples were imaged on inverted
microscope Zeiss AxioObserver A1 equipped with Axiocam MRm R
camera and Plan-Neofluar EC 10 × /0.3 M27 and LD 20 × /0.4
Korr objectives. Images were acquired with AxioVision Rel.4.8
software.
Fluorescent in situ hybridization (FISH) was carried out on cells
that adhered to collagen (Corning) using fluorescent (Fluorescein or
Cy3)-conjugated nick-translated BAC DNA (DNA FISH) or synthetic
DNA oligonucleotides (RNA FISH). Three-dimensional (3D) DNA
FISH on C2C12 was performed with some modifications of an already
described procedure (Cremer et al, 2008). Briefly, cells were fixed in
4% PFA (20 min at 4°C) and pre-processed by freeze-thawing
permeabilization to ensure the preservation of nuclear structures.
After denaturation, FISH probes were hybridized O.N. at 37°C and
samples washed, DAPI-stained, and mounted in ProLong Diamond
reagent (Thermo Fisher Scientific). For DNA FISH on histological
muscle sections, after permeabilization with Triton buffer (0.5%
Triton X-100/PBS), a mild pepsin digestion (pepsin 0.1%/0.1 M
HCl) was applied before denaturation in order to reduce the autoflu-
orescence deriving from protein components. For RNA FISH, fixed
cells were permeabilized in 0.5% Triton (10 min at 4°C) and incu-
bated O.N. at 37°C with fluorescent DNA probes diluted in
hybridization buffer (10% dextran sulfate, 2× SSC, 10% formamide,
2 mM ribonucleoside-vanadyl complex). The specificity of RNA
FISH was tested by pre-incubating the cells with 200 lg/ml RNaseA
for 1 h at 37°C, or by GAPmer transfection. Sequential hybridiza-
tions were used for DNA/RNA FISH. Samples were imaged on
inverted microscope (Olympus IX73) equipped with a Confocal
Imager (CREST X-LIGHT) spinning disk, a CoolSNAP MYO CCD
camera (Photometrics), and a Lumencor Spectra X LED illumina-
tion. Images were acquired with 60× NA1.35 oil objective (UPLAN-
SApo) and MetaMorph (Molecular Devices) using 300 (Cy3), 500
(Fluorescein), or 100 (DAPI) ms as exposure time.
Immunofluorescence and RNA and DNA FISH
post-acquisition analyses
The fusion index (F.I.) indicates the percentage of nuclei in multinu-
cleated myotubes (defined by at least two nuclei) divided by total
number of nuclei in a microscope field; the average number of
nuclei inside individual myotubes (Nu/MT) was determined by
dividing the total number of nuclei by the number of myotubes; and
the fraction of mononucleated MHC-positive cells (MonoMHC+)
was calculated as the mean percentage of nuclei in MHC-positive
cells divided by total number of nuclei in each field. The number of
nuclei was estimated by the average of nuclei counted in three inde-
pendent and randomly chosen microscope fields. Dystrophin stain-
ing was used to evidence the border of the muscle fibers. The
single-channel dystrophin images were merged in dystrophin/DAPI
images with ImageJ software and then used to quantify the fiber
number manually. The fiber cross-sectional area analysis was
performed on dystrophin immunofluorescence by using a semi-
automatic tool (Briguet et al, 2004; Mula et al, 2013). The
immunofluorescence images were binarized to obtain a mask of
fiber boundaries and then applied to originals for the automatic
measure of the areas. Statistical analysis of fiber cross-sectional area
(CSA) was performed using unpaired t-test, and the differences
between means were considered significant at P ≤ 0.05.
For DNA/RNA FISH staining analysis, the Z-stack confocal
microscopy images were taken automatically (0.2-lm path) and
merged with maximum-intensity projection or processed for image
analysis. A Laplacian-of-Gaussian filter was applied to 3D volume
after image acquisition to enhance the spots signal over background
(Raj et al, 2008). Intensity threshold was manually adjusted using
MetaMorph or ImageJ software. Signal from cells hybridized with-
out probes was considered as background.
Spatial proximity analysis of long-splitted, paired, or overlapped
patterns in DNA FISH was performed by computing the 3D interal-
lelic distance on Z-stack acquisitions using ImageJ (Spot Distance;
Schober et al, 2008). Changes in the C2C12 (elliptic) shape of nuclei
occurring along differentiation were taken into account as in Cremer
et al (1984) before the calculation of the Normalized Distances
mean (ND; ND = Interallelic Distances/d, d = major axis + minor
axis/2). Values above or below the paired ND range were attributed
to long-splitted or overlapped patterns, respectively (Fig EV2A). The
co-planarity and the co-localization of the DNA and RNA spots were
established by recording the main grayscale value (expressed as
arbitrary units) along Z-planes using ImageJ (Plot Z-axis profile). A
Gaussian function (determination coefficient > 0.9) was used to fit
the fluorescent intensities and to extrapolate the main Z-plane
value, which corresponds to the maximum fluorescence value of
green and red channels in DNA FISH staining (Fig EV2B). The
percentage of nuclei showing spatial proximity of genomic loci was
calculated by manual screening on binarized images on a total of
about 500 nuclei showing at least one pair of spots with paired or
overlapped patterns. To determine spot intensity (fluorescence
intensity) in RNA FISH analysis, we measured the mean gray value
of nonbinarized images within a selection that circumscribes the
spot; this value was divided by the diameter of the spot (d = 2*((3/
4*V)/p)1/3)) by applying the formula of a sphere with the same
volume of the spot.
Chromatin immunoprecipitation (ChIP)
ChIP experiments were performed on chromatin extracts according
to the manufacturer’s protocol (MAGnify ChIP; Life Technologies)
by O.N. incubation with 2 lg of immobilized monoclonal anti-RNA
ª 2018 The Authors The EMBO Journal e99697 | 2018 13 of 16
Monica Ballarino et al Charme lncRNA functions in myogenesis The EMBO Journal
Published online: September 3, 2018 
Pol II (Millipore), anti-acetyl-histone H3 (Lys9; Millipore), or rabbit
IgG antibodies. A standard curve was generated for each primer pair
testing 5-point dilutions of input sample. Fold enrichment was quan-
tified using qRT–PCR (SYBR Green; Qiagen) and calculated as a
percentage of input chromatin (% Inp). Data from GAP-scr vs. GAP-
2 conditions were normalized to an unrelated genomic region and
represent the mean of three experiments  SEM.
Generation of Charme/ mice
Charme/ mice were generated in the C57BL/6 background using a
CRISPR genome-editing system (Yang et al, 2014). A pair of divergent
single guide RNAs (sgRNAs) inside exon 2 was designed using the
http://crisp.mit.edu resource and cloned into the pX330 vector
(Addgene). The sgRNAs were amplified together with the T7 promoter
to generate templates for in vitro transcription. For homologous
recombination, a ssODN (200 nt) containing two homology arms (50
nt each), a short poly(A) site (49 nt), and two MAZ sites (Levitt et al,
1989; Yonaha & Proudfoot, 2000) was synthetized by IDT. In vitro
transcribed Cas9 mRNA and sgRNAs were injected into the cytoplasm
of fertilized eggs of C57BL/6 mice in M2 medium (Sigma-Aldrich, MO,
USA). Successful knockout was validated by PCR analyses (see
Table EV4 for oligo sequences). The wild-type allele yielded an ampli-
con of 235 bp, whereas the mutated allele yielded an amplicon of
335 bp. One mouse was selected to mate with the wild-type C57BL/6
strain to obtain F1-generation mice. Heterozygous F1 offspring were
interbred to establish the Charme/ strain. Molecular and histologi-
cal analyses were assessed in F4-generation mice.
Offspring genotyping
DNA extraction from tail biopsies was performed using RBC Real
Genomics DNA Extraction Kit (RBC Bioscience) according to the
manufacturer’s protocol. The poly(A)/MAZ insertion was detected
by PCR amplifications with oligo pairs int1b-3 (Table EV4).
Histological analysis
Mice were sacrificed at different ages, and the morphological
changes in the skeletal and cardiac muscles were observed under
light microscopy. Muscle tissues were fixed in 4% formaldehyde,
and sections were stained with hematoxylin and eosin.
Study approval
Animals were treated in respect of housing, nutrition, and care
according to the guidelines of Good Laboratory Practice (GLP). MB
and RT have successfully completed the Module1 as co-coordinated
by the Administration of Animal Facilities in the premises of EMBL.
The EMBL course meets the requirements of European legislation
on basic training of researchers.
Data availability
Data that support the findings of this study have been deposited in
GEO with the primary accession code GSE94498 (https://www.ncbi.
nlm.nih.gov/geo/query/acc.cgi?acc=GSE94498).
Expanded View for this article is available online.
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